{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT00962923",
      "OrgStudyIdInfo": {
        "OrgStudyId": "NJGLYY003"
      },
      "Organization": {
        "OrgFullName": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Allogeneic Mesenchymal Stem Cells Transplantation for Systemic Sclerosis (SSc)"
    },
    "StatusModule": {
      "StatusVerifiedDate": "August 2009",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "August 2009"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "December 2010",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 2011",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "August 19, 2009",
      "StudyFirstSubmitQCDate": "August 19, 2009",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "August 20, 2009",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "August 19, 2009",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "August 20, 2009",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyOldNameTitle": "the Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School",
        "ResponsiblePartyOldOrganization": "the Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School"
      },
      "LeadSponsor": {
        "LeadSponsorName": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "This study will explore safety and efficacy of allogeneic mesenchymal stem cells transplantation (MSCT) to treat patients with diagnosis of systemic sclerosis(SSc) who have been resistant to multiple standard treatments. The underlying hypothesis is that the SSc condition is caused by an abnormal immune homeostasis that can be restored by MSCT.",
      "DetailedDescription": "To test a new approach using allogeneic derived mesenchymal stem cell based therapy (MSCT) to treat refractory SSc\nTo determine the disease-free survival in SSc patients treated with MSCT\nTo assess adverse events of allogeneic MSC transplantation\nTo assess the association of remission for organ function, clinical score and SSc serology levels at baseline with disease-free survival"
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Systemic Sclerosis",
          "Mesenchymal Stem Cells"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Systemic sclerosis",
          "Mesenchymal Stem Cells",
          "Transplantation"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Non-Randomized",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "20",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Allogeneic Mesenchymal Stem Cells (AlloMSC)",
            "InterventionDescription": "Allogeneic mesenchymal stem cells will be infused intravenously (single dose, 10^6 cells/kg body weight)."
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "mRSS score,HRQOL score, SF-36 score for SSc patients",
            "PrimaryOutcomeTimeFrame": "monthly"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Remission for organ function, VC, DLCO, PAP, serum albumin, serum creatitin, weight loss, 24h proteinuria",
            "SecondaryOutcomeTimeFrame": "every three month"
          },
          {
            "SecondaryOutcomeMeasure": "SSc Serology(ATA,ACA,ANA,anti-ssDNA,anti-dsDNA,IgM,IgG,and IgA,complement C3 and C4",
            "SecondaryOutcomeTimeFrame": "every three month"
          },
          {
            "SecondaryOutcomeMeasure": "Change of peripheral blood B and T cells",
            "SecondaryOutcomeTimeFrame": "every three month"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nAll patients fulfilled the American College of Rheumatology (former American Rheumatism Association - ARA) for SSc\nRapidly progressive disease <2 years duration with a modified Rodnan skin score(mRSS) above 20, plus ESR >25 mm/first h and/or Hb <11 g/dL, not explained by other causes than active SSc\nlung involvement: with a vital capacity (VC) or DLCO below 70% predicted, or a mean pulmonary artery pressure (PAP) above 40 mmHg (measured by echocardiography)\ndigestive tract involvement: with serum albumin ,25 g/L or weight loss exceeding 10% body weight in the preceding year\nkidney involvement: with 24-h urinary protein above 0.5 g or serum creatinine above 120 mmol/L\n\nExclusion Criteria:\n\nUncontrolled arrhythmia, echocardiographic left ventricular ejection fraction (LVEF) <50% or mean PAP >50 mmHg, DLCO<45% of predicted\nCreatinine clearance <20 ml/min\nPlatelets<80 000/mm3, haemorrhagic cystitis\n(4) HIV or HTLV1 seropositivity, malignancy, pregnancy, a cardiac or vascular prosthesis, and no vascular access",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "15 Years",
      "MaximumAge": "65 Years",
      "StdAgeList": {
        "StdAge": [
          "Child",
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Lingyun Sun, MD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+86-25-83105219",
            "CentralContactEMail": "lingyunsun2001@yahoo.com.cn"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "the Affiliated Drum Tower Hospital of Nanjing University Medical School",
            "LocationStatus": "Recruiting",
            "LocationCity": "Nanjing",
            "LocationState": "Jiangsu",
            "LocationZip": "210008",
            "LocationCountry": "China",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Yitao Ding, MD",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "+86-25-83106666",
                  "LocationContactPhoneExt": "66866",
                  "LocationContactEMail": "yitaoding@hotmail.com"
                }
              ]
            }
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "19489103",
            "ReferenceType": "background",
            "ReferenceCitation": "Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, Xu T, Le A, Shi S. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells. 2009 Jun;27(6):1421-32. doi: 10.1002/stem.68."
          },
          {
            "ReferencePMID": "19389752",
            "ReferenceType": "background",
            "ReferenceCitation": "Liang J, Zhang H, Hua B, Wang H, Wang J, Han Z, Sun L. Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Mult Scler. 2009 May;15(5):644-6. doi: 10.1177/1352458509104590."
          },
          {
            "ReferencePMID": "19118507",
            "ReferenceType": "background",
            "ReferenceCitation": "Zhou K, Zhang H, Jin O, Feng X, Yao G, Hou Y, Sun L. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell Mol Immunol. 2008 Dec;5(6):417-24. doi: 10.1038/cmi.2008.52."
          },
          {
            "ReferencePMID": "17402368",
            "ReferenceType": "background",
            "ReferenceCitation": "Sun LY, Zhang HY, Feng XB, Hou YY, Lu LW, Fan LM. Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus. 2007;16(2):121-8."
          },
          {
            "ReferencePMID": "28724445",
            "ReferenceType": "derived",
            "ReferenceCitation": "Zhang H, Liang J, Tang X, Wang D, Feng X, Wang F, Hua B, Wang H, Sun L. Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis. Arthritis Res Ther. 2017 Jul 19;19(1):165. doi: 10.1186/s13075-017-1373-2."
          },
          {
            "ReferencePMID": "22542159",
            "ReferenceType": "derived",
            "ReferenceCitation": "Akiyama K, Chen C, Wang D, Xu X, Qu C, Yamaza T, Cai T, Chen W, Sun L, Shi S. Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell. 2012 May 4;10(5):544-55. doi: 10.1016/j.stem.2012.03.007. Epub 2012 Apr 26."
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000012595",
            "ConditionMeshTerm": "Scleroderma, Systemic"
          },
          {
            "ConditionMeshId": "D000045743",
            "ConditionMeshTerm": "Scleroderma, Diffuse"
          },
          {
            "ConditionMeshId": "D000012598",
            "ConditionMeshTerm": "Sclerosis"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000003240",
            "ConditionAncestorTerm": "Connective Tissue Diseases"
          },
          {
            "ConditionAncestorId": "D000012871",
            "ConditionAncestorTerm": "Skin Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M14567",
            "ConditionBrowseLeafName": "Sclerosis",
            "ConditionBrowseLeafAsFound": "Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M14564",
            "ConditionBrowseLeafName": "Scleroderma, Systemic",
            "ConditionBrowseLeafAsFound": "Systemic Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M24713",
            "ConditionBrowseLeafName": "Scleroderma, Diffuse",
            "ConditionBrowseLeafAsFound": "Systemic Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M5616",
            "ConditionBrowseLeafName": "Connective Tissue Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14826",
            "ConditionBrowseLeafName": "Skin Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T5565",
            "ConditionBrowseLeafName": "Systemic Scleroderma",
            "ConditionBrowseLeafAsFound": "Systemic Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    }
  }
}